Pluristem Scoops Up Orphan Drug Designation for PLX-PAD Cells

Pluristem Therapeutics has scooped up FDA orphan drug designation for its PLX-PAD cells for the treatment of severe preeclampsia.

Preeclampsia — which has no cure except delivery — is one of the most common medical complications of pregnancy.